|
Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search |
→ Previous article in this issue (letter by Gelb)
→ Contents list for this issue
Letters
In reply: Gelb points out that clinical pharmacists can, and in some cases do, provide useful communication to general practitioners following hospitalisation, as well as for their patients in aged care facilities. Regrettably, clinical pharmacists are in short supply, even in teaching hospitals; thus, in practice, their expertise often cannot be fully utilised.1 Attention to this shortage is clearly warranted to safeguard patient care.
We agree that clinical pharmacists (hospital and community based) should be included in the Quality Use of Medicines monitoring and evaluation process. In addition, we urge all healthcare providers to take responsibility for careful and timely communication to ensure continuity of patient care.
NSW Therapeutic Assessment Group Inc., Sydney, NSW.
Karen I Kaye, BPharm, DipHospPharm, Executive Officer.Quality Use of Medicines Services, South East Sydney Area Health Service, Darlinghurst, NSW.
Andrea Mant, MD, MA, Adviser.Total Research, Sydney, NSW.
Linda Kehoe, MSc, Consultant.Health Services Project Management, Sydney, NSW.
Wendy C Rotem, MA, MHA, Consultant.Correspondence: Dr A Mant, Quality Use of Medicines Services, South East Sydney Area Health Service, Level 5, 376 Victoria Street, Darlinghurst, NSW.
AntiSpam note: To avoid spam, authors' email addresses are written with AT in place of the usual symbol, and we have removed "mail to" links. Replace AT with the correct symbol to get a valid address.
©The Medical Journal of Australia 2003 www.mja.com.au Print ISSN: 0025-729X Online ISSN: 1326-5377
|
Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search |